Functional analysis of the two cytidine deaminase domains in APOBEC3G.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Virology

• Publication date

  2011-06-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2011.03.014PMID 21489586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Potent Human Antiviral Cytidine Deaminases with 7SL RNA and Viral RNP in HIV-1 Virions

  2010cited by this paper
• Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization

  2009cited by this paper
• A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine Deaminase*

  2009cited by this paper
• RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1

  2009cited by this paper
• Dissecting APOBEC3G Substrate Specificity by Nucleoside Analog Interference*

  2009cited by this paper
• Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA

  2009cited by this paper
• A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity

  2009cited by this paper
• APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts

  2008cited by this paper
• Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.

  2008cited by this paper
• Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G

  2008cited by this paper
• Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H

  2008cited by this paper
• The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals

  2008cited by this paper
• Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.

  2008cited by this paper
• Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication*

  2008cited by this paper
• Model Structure of Human APOBEC3G

  2007cited by this paper
• Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation

  2007cited by this paper
• 7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G

  2007cited by this paper
• APOBEC3G Inhibits DNA Strand Transfer during HIV-1 Reverse Transcription*

  2007cited by this paper
• APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.

  2006cited by this paper
• Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors

  2006cited by this paper
• Inhibition of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{tRNA}_{3}^{\mathrm{Lys}}\) \end{document}-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency

  2006cited by this paper
• Biochemical Activities of Highly Purified, Catalytically Active Human APOBEC3G: Correlation with Antiviral Effect

  2006cited by this paper
• Adaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H

  2006cited by this paper
• Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.

  2005cited by this paper
• Complementary function of the two catalytic domains of APOBEC3G.

  2005cited by this paper
• APOBEC4, a New Member of the AID/APOBEC Family of Polynucleotide (Deoxy)Cytidine Deaminases Predicted by Computational Analysis

  2005cited by this paper
• The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain*

  2005cited by this paper
• Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.

  2005cited by this paper
• Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs*

  2004cited by this paper
• Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression.

  2004cited by this paper
• Rapid evolution of primate antiviral enzyme APOBEC3G.

  2004cited by this paper
• APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication*

  2004cited by this paper
• Retroviral restriction by APOBEC proteins

  2004cited by this paper
• APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles

  2004cited by this paper
• Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G

  2004cited by this paper
• The Interaction between HIV-1 Gag and APOBEC3G*

  2004cited by this paper
• Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging

  2004cited by this paper
• Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

  2003cited by this paper
• The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity

  2003cited by this paper
• HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.

  2003cited by this paper
• Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.

  2003cited by this paper
• Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.

  2003cited by this paper
• HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

  2003cited by this paper
• The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.

  2003cited by this paper
• Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

  2002cited by this paper
• Faculty Opinions recommendation of Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

  2002cited by this paper
• Role of RNA in Facilitating Gag/Gag-Pol Interaction

  2002cited by this paper
• An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

  2002cited by this paper
• Human Immunodeficiency Virus Type 1-Specific Immunity after Genetic Immunization Is Enhanced by Modification of Gag and Pol Expression

  2001cited by this paper
• Efficient Particle Production by Minimal Gag Constructs Which Retain the Carboxy-Terminal Domain of Human Immunodeficiency Virus Type 1 Capsid-p2 and a Late Assembly Domain

  2000cited by this paper
• Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription

  2000cited by this paper
• An Endogenous Inhibitor of Human Immunodeficiency Virus in Human Lymphocytes Is Overcome by the Viral Vif Protein

  1998cited by this paper
• Evidence for a newly discovered cellular anti-HIV-1 phenotype

  1998cited by this paper
• The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes

  1996cited by this paper
• Construction and In Vitro Properties of SIVmac Mutants with Deletions in "Nonessential" Genes

  1994cited by this paper
• Construction and In Vitro Properties of SIVmac Mutants with Deletions in "Nonessential" Genes

  1994cited by this paper
• Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

  1992cited by this paper
• The HIV A (sor) gene product is essential for virus infectivity

  1987cited by this paper
• The sor gene of HIV-1 is required for efficient virus transmission in vitro.

  1987cited by this paper
• A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

  1986cited by this paper
• Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

  1986cited by this paper
• Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.

  1986cited by this paper

• APOBEC3G is a restriction factor of EV71 and mediator of IMB‐Z antiviral activity

  2019cites this paper
• Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor

  2018cites this paper
• Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription

  2018cites this paper
• DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315

  2017cites this paper
• The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.

  2016cites this paper
• Molecular Mechanisms of AID Function

  2015cites this paper
• RNA binding to APOBEC3G induces the disassembly of functional deaminase complexes by displacing single-stranded DNA substrates

  2015cites this paper
• The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells

  2015cites this paper
• The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions

  2014cites this paper
• APOBECs and Their Role in Proviral DNA Synthesis

  2013cites this paper